| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.011 | 0.9 |